Clinically important nail psoriasis improvements are achieved with adalimumab (HUMIRA®):: results from a large open-label prospective study (STEREO)

被引：0
|
作者：
van den Bosch, F. [1 ]
Reece, R. [2 ]
Behrens, F. [3 ]
Wendling, D. [4 ]
Mikkelsen, K. [5 ]
Frank, M. [6 ]
Kron, M. [6 ]
Kupper, H. [6 ]
机构：
[1] Ghent Univ Hosp, B-9000 Ghent, Belgium
[2] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England
[3] Goethe Univ Frankfurt, Frankfurt, Germany
[4] Univ Franche Comte, F-25030 Besancon, France
[5] Hosp Rheumat Dis, Lillehammer, Norway
[6] Abbott GmbH & Co KG, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：421 / 421
页数：1
相关论文
共 50 条
  • [41] Ixekizumab treatment improves nail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized and controlled as well as open-label phases of UNCOVER-3
    van de Kerkhof, P.
    Guenther, L.
    Gottlieb, A.
    Sebastian, M.
    Wu, J.
    Foley, P.
    Morita, A.
    Goldblum, O.
    Zhang, L.
    Erickson, J.
    Ball, S.
    Rich, P.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 69 - 69
  • [42] Results of a large open-label safety study of daxibotulinumtoxina for injection in glabellar lines
    Guillen-Fabi, Sabrina
    Green, Jeremy B.
    Liu, Yan
    Rubio, Roman G.
    Gallagher, Conor J.
    Gross, Todd M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB98 - AB98
  • [43] Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
    Pivonello, Rosario
    Bancos, Irina
    Feelders, Richard A. A.
    Kargi, Atil Y. Y.
    Kerr, Janice M. M.
    Gordon, Murray B. B.
    Mariash, Cary N. N.
    Terzolo, Massimo
    Ellison, Noel
    Moraitis, Andreas G. G.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [44] Amoxapine shows atypical antipsychotic effects in patients with schizophrenia: results from a prospective open-label study
    Apiquian, R
    Ulloa, E
    Fresan, A
    Loyzaga, C
    Nicolini, H
    Kapur, S
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 59 (01) : 35 - 39
  • [45] Early Visible Improvements during K101-03 Treatment: An Open-Label Multicenter Clinical Investigation in Patients with Onychomycosis and/or Nail Psoriasis
    Piraccini, Bianca Maria
    Starace, Michela
    Toft, Anders
    [J]. DERMATOLOGY, 2017, 233 (2-3) : 178 - 183
  • [46] Treatment of nail psoriasis with tumor necrosis factor-alpha blocker agents: An open-label, unblinded, comparative study
    Ozmen, Ibrahim
    Erbil, Ahmet Hakan
    Koc, Erol
    Tunca, Mustafa
    [J]. JOURNAL OF DERMATOLOGY, 2013, 40 (09): : 755 - 756
  • [47] Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study
    Wetwittayakhlang, Panu
    Verdon, Christine
    Starr, Michael
    Hahn, Gustavo Drugg
    Golovics, Petra A.
    Bessissow, Talat
    Afif, Waqqas
    Wild, Gary
    Bitton, Alain
    Lakatos, Peter L.
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (06): : 603 - 610
  • [48] The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
    Gottlieb, Alice B.
    Kalb, Robert E.
    Blauvelt, Andrew
    Heffernan, Michael P.
    Sofen, Howard L.
    Ferris, Laura Korb
    Kerdel, Francisco A.
    Calabro, Stephen
    Wang, Jim
    Kerkmann, Urs
    Chevrier, Marc
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) : 642 - 650
  • [49] Fumaric-acid esters (Fumaderm®) for severe, treatment resistant psoriasis:: a prospective, open-label study
    Smith, CH
    Jones, E
    Wain, M
    Barker, JNWN
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [50] Results from an open-label extension study of etanercept in ankylosing spondylitis
    Davis, J
    Webb, A
    Lund, S
    Sack, K
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 302 - 304
12345